Outcomes of Kimura's disease after radiotherapy or nonradiotherapeutic treatment modalities

Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):1233-9. doi: 10.1016/j.ijrobp.2006.02.024. Epub 2006 Jun 5.

Abstract

Purpose: To evaluate the clinical outcome of Kimura's disease and to identify the optimal treatment regimen for Kimura's disease.

Methods and materials: Between 1984 and 2003, 14 patients with Kimura's disease were treated with radiotherapy (RT) and 9 patients were treated with local excision or systemic steroids. The radiation doses ranged from 20 to 45 Gy. Immunohistochemical studies were performed in 13 cases.

Results: At RT completion, a marked response in terms of tumor size was noted in most cases. The median follow-up was 65 months. Local control was obtained in 9 (64.3%) of the 14 in the RT group and in 2 (22.2%) of the 9 in the non-RT group. No secondary malignancies were observed in the RT group.

Conclusion: These results supports the finding that RT is more effective against Kimura's disease. Simple or immunohistochemical features did not influence the treatment outcome.

MeSH terms

  • Adolescent
  • Adult
  • Angiolymphoid Hyperplasia with Eosinophilia / drug therapy*
  • Angiolymphoid Hyperplasia with Eosinophilia / pathology
  • Angiolymphoid Hyperplasia with Eosinophilia / radiotherapy*
  • Child
  • Female
  • Glucocorticoids / therapeutic use*
  • Humans
  • Male
  • Middle Aged
  • Prednisolone / therapeutic use*
  • Radiotherapy Dosage
  • Remission Induction
  • Treatment Outcome

Substances

  • Glucocorticoids
  • Prednisolone